Reflocibart Biosimilar - Research Grade

Human

VEGFBï؟½

5mg/ml

IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P49765

Blue ice

VEGFB is a vascular endothelial growth factor family member with roles in metabolism, neuroprotection, and endothelial signaling. This human IgG4 kappa antibody is an unconjugated, non-therapeutic analog of reflocibart, expressed in CHO cells against human VEGFB. Released for research use only, it is purified to low endotoxin for in vivo compatibility and produced in scalable milligram (mg) to gram (g) quantities for high-throughput laboratories. It serves as a consistent reagent for growth-factor neutralization assays, receptor-signaling studies, functional readouts, and preclinical vascular and metabolic models. Consistent lot-to-lot performance makes it dependable for repeated, large-scale experimentation.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks